Danaher Corporation
Danaher Corporation 0R2B.L Peers
See (0R2B.L) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Equipment & Services Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| 0R2B.L | $188.51 | -4.68% | 134.91B | 21.82 | $8.64 | +0.60% |
| 0R29.L | $549.77 | -0.83% | 197.05B | 122.44 | $4.49 | N/A |
| 0HOY.L | $105.22 | -0.87% | 155.67B | 198.53 | $0.53 | N/A |
| 0R2S.L | $381.71 | -2.09% | 145.88B | 72.58 | $5.26 | +0.86% |
| 0Y6X.L | $85.14 | -1.54% | 109.19B | 22.82 | $3.73 | +3.29% |
| 0J1R.L | $381.67 | -1.51% | 91.82B | 17.93 | $21.29 | +0.71% |
| 0HG8.L | $403.04 | -2.23% | 91.06B | 15.87 | $25.40 | +1.64% |
| 0JZU.L | $717.82 | -1.27% | 89.81B | 99.31 | $7.23 | +0.38% |
| 0HRS.L | $62.30 | -2.67% | 78.81B | 10.36 | $6.01 | +4.27% |
| 0PMJ.L | $48.83 | -0.32% | 54.77B | 28.88 | $1.69 | +1.95% |
Stock Comparison
0R2B.L vs 0R29.L Comparison
0R2B.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0R2B.L stands at 134.91B. In comparison, 0R29.L has a market cap of 197.05B. Regarding current trading prices, 0R2B.L is priced at $188.51, while 0R29.L trades at $549.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0R2B.L currently has a P/E ratio of 21.82, whereas 0R29.L's P/E ratio is 122.44. In terms of profitability, 0R2B.L's ROE is +0.07%, compared to 0R29.L's ROE of +0.16%. Regarding short-term risk, 0R2B.L is more volatile compared to 0R29.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0R2B.L.
0R2B.L vs 0HOY.L Comparison
0R2B.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0R2B.L stands at 134.91B. In comparison, 0HOY.L has a market cap of 155.67B. Regarding current trading prices, 0R2B.L is priced at $188.51, while 0HOY.L trades at $105.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0R2B.L currently has a P/E ratio of 21.82, whereas 0HOY.L's P/E ratio is 198.53. In terms of profitability, 0R2B.L's ROE is +0.07%, compared to 0HOY.L's ROE of +0.10%. Regarding short-term risk, 0R2B.L is more volatile compared to 0HOY.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0R2B.L.
0R2B.L vs 0R2S.L Comparison
0R2B.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0R2B.L stands at 134.91B. In comparison, 0R2S.L has a market cap of 145.88B. Regarding current trading prices, 0R2B.L is priced at $188.51, while 0R2S.L trades at $381.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0R2B.L currently has a P/E ratio of 21.82, whereas 0R2S.L's P/E ratio is 72.58. In terms of profitability, 0R2B.L's ROE is +0.07%, compared to 0R2S.L's ROE of +0.11%. Regarding short-term risk, 0R2B.L is more volatile compared to 0R2S.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0R2B.L.
0R2B.L vs 0Y6X.L Comparison
0R2B.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0R2B.L stands at 134.91B. In comparison, 0Y6X.L has a market cap of 109.19B. Regarding current trading prices, 0R2B.L is priced at $188.51, while 0Y6X.L trades at $85.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0R2B.L currently has a P/E ratio of 21.82, whereas 0Y6X.L's P/E ratio is 22.82. In terms of profitability, 0R2B.L's ROE is +0.07%, compared to 0Y6X.L's ROE of +0.09%. Regarding short-term risk, 0R2B.L is more volatile compared to 0Y6X.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0R2B.L.
0R2B.L vs 0J1R.L Comparison
0R2B.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0R2B.L stands at 134.91B. In comparison, 0J1R.L has a market cap of 91.82B. Regarding current trading prices, 0R2B.L is priced at $188.51, while 0J1R.L trades at $381.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0R2B.L currently has a P/E ratio of 21.82, whereas 0J1R.L's P/E ratio is 17.93. In terms of profitability, 0R2B.L's ROE is +0.07%, compared to 0J1R.L's ROE of -2.36%. Regarding short-term risk, 0R2B.L is more volatile compared to 0J1R.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0R2B.L.
0R2B.L vs 0HG8.L Comparison
0R2B.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0R2B.L stands at 134.91B. In comparison, 0HG8.L has a market cap of 91.06B. Regarding current trading prices, 0R2B.L is priced at $188.51, while 0HG8.L trades at $403.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0R2B.L currently has a P/E ratio of 21.82, whereas 0HG8.L's P/E ratio is 15.87. In terms of profitability, 0R2B.L's ROE is +0.07%, compared to 0HG8.L's ROE of +0.14%. Regarding short-term risk, 0R2B.L is more volatile compared to 0HG8.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0R2B.L.
0R2B.L vs 0JZU.L Comparison
0R2B.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0R2B.L stands at 134.91B. In comparison, 0JZU.L has a market cap of 89.81B. Regarding current trading prices, 0R2B.L is priced at $188.51, while 0JZU.L trades at $717.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0R2B.L currently has a P/E ratio of 21.82, whereas 0JZU.L's P/E ratio is 99.31. In terms of profitability, 0R2B.L's ROE is +0.07%, compared to 0JZU.L's ROE of -1.15%. Regarding short-term risk, 0R2B.L is more volatile compared to 0JZU.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0R2B.L.
0R2B.L vs 0HRS.L Comparison
0R2B.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0R2B.L stands at 134.91B. In comparison, 0HRS.L has a market cap of 78.81B. Regarding current trading prices, 0R2B.L is priced at $188.51, while 0HRS.L trades at $62.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0R2B.L currently has a P/E ratio of 21.82, whereas 0HRS.L's P/E ratio is 10.36. In terms of profitability, 0R2B.L's ROE is +0.07%, compared to 0HRS.L's ROE of +0.07%. Regarding short-term risk, 0R2B.L is more volatile compared to 0HRS.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0R2B.L.
0R2B.L vs 0PMJ.L Comparison
0R2B.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0R2B.L stands at 134.91B. In comparison, 0PMJ.L has a market cap of 54.77B. Regarding current trading prices, 0R2B.L is priced at $188.51, while 0PMJ.L trades at $48.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0R2B.L currently has a P/E ratio of 21.82, whereas 0PMJ.L's P/E ratio is 28.88. In terms of profitability, 0R2B.L's ROE is +0.07%, compared to 0PMJ.L's ROE of +0.11%. Regarding short-term risk, 0R2B.L is more volatile compared to 0PMJ.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0R2B.L.
0R2B.L vs 0R19.L Comparison
0R2B.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0R2B.L stands at 134.91B. In comparison, 0R19.L has a market cap of 49.78B. Regarding current trading prices, 0R2B.L is priced at $188.51, while 0R19.L trades at $173.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0R2B.L currently has a P/E ratio of 21.82, whereas 0R19.L's P/E ratio is 27.42. In terms of profitability, 0R2B.L's ROE is +0.07%, compared to 0R19.L's ROE of +0.07%. Regarding short-term risk, 0R2B.L is more volatile compared to 0R19.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0R2B.L.
0R2B.L vs 0J8P.L Comparison
0R2B.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0R2B.L stands at 134.91B. In comparison, 0J8P.L has a market cap of 40.27B. Regarding current trading prices, 0R2B.L is priced at $188.51, while 0J8P.L trades at $500.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0R2B.L currently has a P/E ratio of 21.82, whereas 0J8P.L's P/E ratio is 58.80. In terms of profitability, 0R2B.L's ROE is +0.07%, compared to 0J8P.L's ROE of +0.57%. Regarding short-term risk, 0R2B.L is more volatile compared to 0J8P.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0R2B.L.
0R2B.L vs 0LO3.L Comparison
0R2B.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0R2B.L stands at 134.91B. In comparison, 0LO3.L has a market cap of 38.30B. Regarding current trading prices, 0R2B.L is priced at $188.51, while 0LO3.L trades at $235.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0R2B.L currently has a P/E ratio of 21.82, whereas 0LO3.L's P/E ratio is 92.54. In terms of profitability, 0R2B.L's ROE is +0.07%, compared to 0LO3.L's ROE of +0.13%. Regarding short-term risk, 0R2B.L is more volatile compared to 0LO3.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0R2B.L.
0R2B.L vs 0RPS.L Comparison
0R2B.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0R2B.L stands at 134.91B. In comparison, 0RPS.L has a market cap of 36.84B. Regarding current trading prices, 0R2B.L is priced at $188.51, while 0RPS.L trades at $242.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0R2B.L currently has a P/E ratio of 21.82, whereas 0RPS.L's P/E ratio is 408.25. In terms of profitability, 0R2B.L's ROE is +0.07%, compared to 0RPS.L's ROE of +0.06%. Regarding short-term risk, 0R2B.L is more volatile compared to 0RPS.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0R2B.L.
0R2B.L vs 0HTG.L Comparison
0R2B.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0R2B.L stands at 134.91B. In comparison, 0HTG.L has a market cap of 36.62B. Regarding current trading prices, 0R2B.L is priced at $188.51, while 0HTG.L trades at $153.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0R2B.L currently has a P/E ratio of 21.82, whereas 0HTG.L's P/E ratio is -45.44. In terms of profitability, 0R2B.L's ROE is +0.07%, compared to 0HTG.L's ROE of -0.50%. Regarding short-term risk, 0R2B.L is more volatile compared to 0HTG.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0R2B.L.
0R2B.L vs 0KW4.L Comparison
0R2B.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0R2B.L stands at 134.91B. In comparison, 0KW4.L has a market cap of 35.86B. Regarding current trading prices, 0R2B.L is priced at $188.51, while 0KW4.L trades at $244.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0R2B.L currently has a P/E ratio of 21.82, whereas 0KW4.L's P/E ratio is 46.15. In terms of profitability, 0R2B.L's ROE is +0.07%, compared to 0KW4.L's ROE of +0.25%. Regarding short-term risk, 0R2B.L is more volatile compared to 0KW4.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0R2B.L.
0R2B.L vs 0HVB.L Comparison
0R2B.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0R2B.L stands at 134.91B. In comparison, 0HVB.L has a market cap of 30.45B. Regarding current trading prices, 0R2B.L is priced at $188.51, while 0HVB.L trades at $61.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0R2B.L currently has a P/E ratio of 21.82, whereas 0HVB.L's P/E ratio is 24.18. In terms of profitability, 0R2B.L's ROE is +0.07%, compared to 0HVB.L's ROE of +0.13%. Regarding short-term risk, 0R2B.L is more volatile compared to 0HVB.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0R2B.L.
0R2B.L vs 0J6Z.L Comparison
0R2B.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0R2B.L stands at 134.91B. In comparison, 0J6Z.L has a market cap of 29.97B. Regarding current trading prices, 0R2B.L is priced at $188.51, while 0J6Z.L trades at $248.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0R2B.L currently has a P/E ratio of 21.82, whereas 0J6Z.L's P/E ratio is 10.54. In terms of profitability, 0R2B.L's ROE is +0.07%, compared to 0J6Z.L's ROE of +0.07%. Regarding short-term risk, 0R2B.L is more volatile compared to 0J6Z.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0R2B.L.
0R2B.L vs NIOX.L Comparison
0R2B.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0R2B.L stands at 134.91B. In comparison, NIOX.L has a market cap of 26.34B. Regarding current trading prices, 0R2B.L is priced at $188.51, while NIOX.L trades at $65.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0R2B.L currently has a P/E ratio of 21.82, whereas NIOX.L's P/E ratio is 6500.00. In terms of profitability, 0R2B.L's ROE is +0.07%, compared to NIOX.L's ROE of +0.05%. Regarding short-term risk, 0R2B.L is less volatile compared to NIOX.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0R2B.L.
0R2B.L vs 0JSY.L Comparison
0R2B.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0R2B.L stands at 134.91B. In comparison, 0JSY.L has a market cap of 21.18B. Regarding current trading prices, 0R2B.L is priced at $188.51, while 0JSY.L trades at $253.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0R2B.L currently has a P/E ratio of 21.82, whereas 0JSY.L's P/E ratio is 11.62. In terms of profitability, 0R2B.L's ROE is +0.07%, compared to 0JSY.L's ROE of +0.09%. Regarding short-term risk, 0R2B.L is more volatile compared to 0JSY.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0R2B.L.
0R2B.L vs 0KSX.L Comparison
0R2B.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0R2B.L stands at 134.91B. In comparison, 0KSX.L has a market cap of 19.15B. Regarding current trading prices, 0R2B.L is priced at $188.51, while 0KSX.L trades at $171.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0R2B.L currently has a P/E ratio of 21.82, whereas 0KSX.L's P/E ratio is 11.38. In terms of profitability, 0R2B.L's ROE is +0.07%, compared to 0KSX.L's ROE of +0.13%. Regarding short-term risk, 0R2B.L is more volatile compared to 0KSX.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0R2B.L.
0R2B.L vs 0QK8.L Comparison
0R2B.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0R2B.L stands at 134.91B. In comparison, 0QK8.L has a market cap of 15.79B. Regarding current trading prices, 0R2B.L is priced at $188.51, while 0QK8.L trades at $30.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0R2B.L currently has a P/E ratio of 21.82, whereas 0QK8.L's P/E ratio is 14.73. In terms of profitability, 0R2B.L's ROE is +0.07%, compared to 0QK8.L's ROE of -0.08%. Regarding short-term risk, 0R2B.L is more volatile compared to 0QK8.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0R2B.L.
0R2B.L vs 0NIQ.L Comparison
0R2B.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0R2B.L stands at 134.91B. In comparison, 0NIQ.L has a market cap of 14.34B. Regarding current trading prices, 0R2B.L is priced at $188.51, while 0NIQ.L trades at $185.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0R2B.L currently has a P/E ratio of 21.82, whereas 0NIQ.L's P/E ratio is 29.25. In terms of profitability, 0R2B.L's ROE is +0.07%, compared to 0NIQ.L's ROE of +0.04%. Regarding short-term risk, 0R2B.L is more volatile compared to 0NIQ.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0R2B.L.
0R2B.L vs 0HCK.L Comparison
0R2B.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0R2B.L stands at 134.91B. In comparison, 0HCK.L has a market cap of 12.61B. Regarding current trading prices, 0R2B.L is priced at $188.51, while 0HCK.L trades at $174.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0R2B.L currently has a P/E ratio of 21.82, whereas 0HCK.L's P/E ratio is 19.59. In terms of profitability, 0R2B.L's ROE is +0.07%, compared to 0HCK.L's ROE of +0.11%. Regarding short-term risk, 0R2B.L is more volatile compared to 0HCK.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0R2B.L.
0R2B.L vs 0J5Q.L Comparison
0R2B.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0R2B.L stands at 134.91B. In comparison, 0J5Q.L has a market cap of 12.30B. Regarding current trading prices, 0R2B.L is priced at $188.51, while 0J5Q.L trades at $55.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0R2B.L currently has a P/E ratio of 21.82, whereas 0J5Q.L's P/E ratio is 9.12. In terms of profitability, 0R2B.L's ROE is +0.07%, compared to 0J5Q.L's ROE of +0.15%. Regarding short-term risk, 0R2B.L is more volatile compared to 0J5Q.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0R2B.L.
0R2B.L vs 0LJL.L Comparison
0R2B.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0R2B.L stands at 134.91B. In comparison, 0LJL.L has a market cap of 12.21B. Regarding current trading prices, 0R2B.L is priced at $188.51, while 0LJL.L trades at $190.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0R2B.L currently has a P/E ratio of 21.82, whereas 0LJL.L's P/E ratio is 16.56. In terms of profitability, 0R2B.L's ROE is +0.07%, compared to 0LJL.L's ROE of +0.18%. Regarding short-term risk, 0R2B.L is more volatile compared to 0LJL.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0R2B.L.
0R2B.L vs 0I7E.L Comparison
0R2B.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0R2B.L stands at 134.91B. In comparison, 0I7E.L has a market cap of 10.71B. Regarding current trading prices, 0R2B.L is priced at $188.51, while 0I7E.L trades at $141.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0R2B.L currently has a P/E ratio of 21.82, whereas 0I7E.L's P/E ratio is 16.76. In terms of profitability, 0R2B.L's ROE is +0.07%, compared to 0I7E.L's ROE of +3.94%. Regarding short-term risk, 0R2B.L is more volatile compared to 0I7E.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0R2B.L.
0R2B.L vs 0RKL.L Comparison
0R2B.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0R2B.L stands at 134.91B. In comparison, 0RKL.L has a market cap of 9.77B. Regarding current trading prices, 0R2B.L is priced at $188.51, while 0RKL.L trades at $310.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0R2B.L currently has a P/E ratio of 21.82, whereas 0RKL.L's P/E ratio is 1308.86. In terms of profitability, 0R2B.L's ROE is +0.07%, compared to 0RKL.L's ROE of +0.07%. Regarding short-term risk, 0R2B.L is more volatile compared to 0RKL.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0R2B.L.
0R2B.L vs 0L3C.L Comparison
0R2B.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0R2B.L stands at 134.91B. In comparison, 0L3C.L has a market cap of 8.91B. Regarding current trading prices, 0R2B.L is priced at $188.51, while 0L3C.L trades at $73.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0R2B.L currently has a P/E ratio of 21.82, whereas 0L3C.L's P/E ratio is 15.96. In terms of profitability, 0R2B.L's ROE is +0.07%, compared to 0L3C.L's ROE of +0.12%. Regarding short-term risk, 0R2B.L is more volatile compared to 0L3C.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0R2B.L.
0R2B.L vs 0JZ2.L Comparison
0R2B.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0R2B.L stands at 134.91B. In comparison, 0JZ2.L has a market cap of 8.41B. Regarding current trading prices, 0R2B.L is priced at $188.51, while 0JZ2.L trades at $155.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0R2B.L currently has a P/E ratio of 21.82, whereas 0JZ2.L's P/E ratio is 40.08. In terms of profitability, 0R2B.L's ROE is +0.07%, compared to 0JZ2.L's ROE of -0.41%. Regarding short-term risk, 0R2B.L is more volatile compared to 0JZ2.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0R2B.L.
0R2B.L vs 0QLQ.L Comparison
0R2B.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0R2B.L stands at 134.91B. In comparison, 0QLQ.L has a market cap of 4.65B. Regarding current trading prices, 0R2B.L is priced at $188.51, while 0QLQ.L trades at $361.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0R2B.L currently has a P/E ratio of 21.82, whereas 0QLQ.L's P/E ratio is 197.59. In terms of profitability, 0R2B.L's ROE is +0.07%, compared to 0QLQ.L's ROE of +0.12%. Regarding short-term risk, 0R2B.L is less volatile compared to 0QLQ.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0R2B.L.
0R2B.L vs 0ROG.L Comparison
0R2B.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0R2B.L stands at 134.91B. In comparison, 0ROG.L has a market cap of 4.40B. Regarding current trading prices, 0R2B.L is priced at $188.51, while 0ROG.L trades at $88.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0R2B.L currently has a P/E ratio of 21.82, whereas 0ROG.L's P/E ratio is 26.10. In terms of profitability, 0R2B.L's ROE is +0.07%, compared to 0ROG.L's ROE of +0.12%. Regarding short-term risk, 0R2B.L is more volatile compared to 0ROG.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0R2B.L.
0R2B.L vs 0OCD.L Comparison
0R2B.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0R2B.L stands at 134.91B. In comparison, 0OCD.L has a market cap of 3.83B. Regarding current trading prices, 0R2B.L is priced at $188.51, while 0OCD.L trades at $209.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0R2B.L currently has a P/E ratio of 21.82, whereas 0OCD.L's P/E ratio is 41.14. In terms of profitability, 0R2B.L's ROE is +0.07%, compared to 0OCD.L's ROE of +0.25%. Regarding short-term risk, 0R2B.L is more volatile compared to 0OCD.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0R2B.L.
0R2B.L vs 0A05.L Comparison
0R2B.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0R2B.L stands at 134.91B. In comparison, 0A05.L has a market cap of 2.79B. Regarding current trading prices, 0R2B.L is priced at $188.51, while 0A05.L trades at $140.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0R2B.L currently has a P/E ratio of 21.82, whereas 0A05.L's P/E ratio is 53.47. In terms of profitability, 0R2B.L's ROE is +0.07%, compared to 0A05.L's ROE of +0.16%. Regarding short-term risk, 0R2B.L is more volatile compared to 0A05.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0R2B.L.
0R2B.L vs 0KGB.L Comparison
0R2B.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0R2B.L stands at 134.91B. In comparison, 0KGB.L has a market cap of 2.77B. Regarding current trading prices, 0R2B.L is priced at $188.51, while 0KGB.L trades at $31.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0R2B.L currently has a P/E ratio of 21.82, whereas 0KGB.L's P/E ratio is 18.29. In terms of profitability, 0R2B.L's ROE is +0.07%, compared to 0KGB.L's ROE of +0.14%. Regarding short-term risk, 0R2B.L is more volatile compared to 0KGB.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0R2B.L.
0R2B.L vs 0A23.L Comparison
0R2B.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0R2B.L stands at 134.91B. In comparison, 0A23.L has a market cap of 1.49B. Regarding current trading prices, 0R2B.L is priced at $188.51, while 0A23.L trades at $28.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0R2B.L currently has a P/E ratio of 21.82, whereas 0A23.L's P/E ratio is -9.27. In terms of profitability, 0R2B.L's ROE is +0.07%, compared to 0A23.L's ROE of -0.23%. Regarding short-term risk, 0R2B.L is more volatile compared to 0A23.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0R2B.L.
0R2B.L vs 0QV2.L Comparison
0R2B.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0R2B.L stands at 134.91B. In comparison, 0QV2.L has a market cap of 1.28B. Regarding current trading prices, 0R2B.L is priced at $188.51, while 0QV2.L trades at $74.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0R2B.L currently has a P/E ratio of 21.82, whereas 0QV2.L's P/E ratio is -40.50. In terms of profitability, 0R2B.L's ROE is +0.07%, compared to 0QV2.L's ROE of -0.08%. Regarding short-term risk, 0R2B.L is more volatile compared to 0QV2.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0R2B.L.
0R2B.L vs 0K0K.L Comparison
0R2B.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0R2B.L stands at 134.91B. In comparison, 0K0K.L has a market cap of 1.24B. Regarding current trading prices, 0R2B.L is priced at $188.51, while 0K0K.L trades at $33.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0R2B.L currently has a P/E ratio of 21.82, whereas 0K0K.L's P/E ratio is 21.09. In terms of profitability, 0R2B.L's ROE is +0.07%, compared to 0K0K.L's ROE of +0.12%. Regarding short-term risk, Volatility data is not available for a full comparison. 0R2B.L has daily volatility of 4.62 and 0K0K.L has daily volatility of N/A.
0R2B.L vs 0LDR.L Comparison
0R2B.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0R2B.L stands at 134.91B. In comparison, 0LDR.L has a market cap of 1.24B. Regarding current trading prices, 0R2B.L is priced at $188.51, while 0LDR.L trades at $7.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0R2B.L currently has a P/E ratio of 21.82, whereas 0LDR.L's P/E ratio is -0.16. In terms of profitability, 0R2B.L's ROE is +0.07%, compared to 0LDR.L's ROE of -0.68%. Regarding short-term risk, 0R2B.L is more volatile compared to 0LDR.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0R2B.L.
0R2B.L vs 0FGL.L Comparison
0R2B.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0R2B.L stands at 134.91B. In comparison, 0FGL.L has a market cap of 1.24B. Regarding current trading prices, 0R2B.L is priced at $188.51, while 0FGL.L trades at $71.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0R2B.L currently has a P/E ratio of 21.82, whereas 0FGL.L's P/E ratio is 64.02. In terms of profitability, 0R2B.L's ROE is +0.07%, compared to 0FGL.L's ROE of +0.12%. Regarding short-term risk, 0R2B.L is more volatile compared to 0FGL.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0R2B.L.
0R2B.L vs 0S9E.L Comparison
0R2B.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0R2B.L stands at 134.91B. In comparison, 0S9E.L has a market cap of 1.20B. Regarding current trading prices, 0R2B.L is priced at $188.51, while 0S9E.L trades at $12.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0R2B.L currently has a P/E ratio of 21.82, whereas 0S9E.L's P/E ratio is 161.25. In terms of profitability, 0R2B.L's ROE is +0.07%, compared to 0S9E.L's ROE of +0.66%. Regarding short-term risk, 0R2B.L is more volatile compared to 0S9E.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0R2B.L.
0R2B.L vs 0MT8.L Comparison
0R2B.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0R2B.L stands at 134.91B. In comparison, 0MT8.L has a market cap of 1.08B. Regarding current trading prices, 0R2B.L is priced at $188.51, while 0MT8.L trades at $53.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0R2B.L currently has a P/E ratio of 21.82, whereas 0MT8.L's P/E ratio is 7.40. In terms of profitability, 0R2B.L's ROE is +0.07%, compared to 0MT8.L's ROE of +0.09%. Regarding short-term risk, 0R2B.L is more volatile compared to 0MT8.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0R2B.L.
0R2B.L vs 0KFH.L Comparison
0R2B.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0R2B.L stands at 134.91B. In comparison, 0KFH.L has a market cap of 776.63M. Regarding current trading prices, 0R2B.L is priced at $188.51, while 0KFH.L trades at $29.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0R2B.L currently has a P/E ratio of 21.82, whereas 0KFH.L's P/E ratio is 42.50. In terms of profitability, 0R2B.L's ROE is +0.07%, compared to 0KFH.L's ROE of +0.18%. Regarding short-term risk, 0R2B.L is more volatile compared to 0KFH.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0R2B.L.
0R2B.L vs 0R9T.L Comparison
0R2B.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0R2B.L stands at 134.91B. In comparison, 0R9T.L has a market cap of 765.10M. Regarding current trading prices, 0R2B.L is priced at $188.51, while 0R9T.L trades at $50.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0R2B.L currently has a P/E ratio of 21.82, whereas 0R9T.L's P/E ratio is 19.73. In terms of profitability, 0R2B.L's ROE is +0.07%, compared to 0R9T.L's ROE of +0.16%. Regarding short-term risk, 0R2B.L is more volatile compared to 0R9T.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0R2B.L.
0R2B.L vs 0HKD.L Comparison
0R2B.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0R2B.L stands at 134.91B. In comparison, 0HKD.L has a market cap of 535.60M. Regarding current trading prices, 0R2B.L is priced at $188.51, while 0HKD.L trades at $11.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0R2B.L currently has a P/E ratio of 21.82, whereas 0HKD.L's P/E ratio is -15.35. In terms of profitability, 0R2B.L's ROE is +0.07%, compared to 0HKD.L's ROE of -0.07%. Regarding short-term risk, 0R2B.L is more volatile compared to 0HKD.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0R2B.L.
0R2B.L vs 0QLX.L Comparison
0R2B.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0R2B.L stands at 134.91B. In comparison, 0QLX.L has a market cap of 477.43M. Regarding current trading prices, 0R2B.L is priced at $188.51, while 0QLX.L trades at $1,070.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0R2B.L currently has a P/E ratio of 21.82, whereas 0QLX.L's P/E ratio is 9.83. In terms of profitability, 0R2B.L's ROE is +0.07%, compared to 0QLX.L's ROE of +0.12%. Regarding short-term risk, 0R2B.L is more volatile compared to 0QLX.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0R2B.L.
0R2B.L vs 0QP7.L Comparison
0R2B.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0R2B.L stands at 134.91B. In comparison, 0QP7.L has a market cap of 388.40M. Regarding current trading prices, 0R2B.L is priced at $188.51, while 0QP7.L trades at $65.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0R2B.L currently has a P/E ratio of 21.82, whereas 0QP7.L's P/E ratio is 12.25. In terms of profitability, 0R2B.L's ROE is +0.07%, compared to 0QP7.L's ROE of +0.20%. Regarding short-term risk, 0R2B.L is more volatile compared to 0QP7.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0R2B.L.
0R2B.L vs 0RAR.L Comparison
0R2B.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0R2B.L stands at 134.91B. In comparison, 0RAR.L has a market cap of 346.44M. Regarding current trading prices, 0R2B.L is priced at $188.51, while 0RAR.L trades at $28.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0R2B.L currently has a P/E ratio of 21.82, whereas 0RAR.L's P/E ratio is 8.77. In terms of profitability, 0R2B.L's ROE is +0.07%, compared to 0RAR.L's ROE of +0.04%. Regarding short-term risk, 0R2B.L is less volatile compared to 0RAR.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0R2B.L.
0R2B.L vs 0QB4.L Comparison
0R2B.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0R2B.L stands at 134.91B. In comparison, 0QB4.L has a market cap of 308.62M. Regarding current trading prices, 0R2B.L is priced at $188.51, while 0QB4.L trades at $12.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0R2B.L currently has a P/E ratio of 21.82, whereas 0QB4.L's P/E ratio is 26.83. In terms of profitability, 0R2B.L's ROE is +0.07%, compared to 0QB4.L's ROE of +0.03%. Regarding short-term risk, 0R2B.L is more volatile compared to 0QB4.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0R2B.L.
0R2B.L vs 0ELV.L Comparison
0R2B.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0R2B.L stands at 134.91B. In comparison, 0ELV.L has a market cap of 251.57M. Regarding current trading prices, 0R2B.L is priced at $188.51, while 0ELV.L trades at $19.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0R2B.L currently has a P/E ratio of 21.82, whereas 0ELV.L's P/E ratio is 7.74. In terms of profitability, 0R2B.L's ROE is +0.07%, compared to 0ELV.L's ROE of +0.04%. Regarding short-term risk, 0R2B.L is more volatile compared to 0ELV.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0R2B.L.
0R2B.L vs 0OR2.L Comparison
0R2B.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0R2B.L stands at 134.91B. In comparison, 0OR2.L has a market cap of 248.47M. Regarding current trading prices, 0R2B.L is priced at $188.51, while 0OR2.L trades at $24.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0R2B.L currently has a P/E ratio of 21.82, whereas 0OR2.L's P/E ratio is 9.91. In terms of profitability, 0R2B.L's ROE is +0.07%, compared to 0OR2.L's ROE of +0.07%. Regarding short-term risk, 0R2B.L is more volatile compared to 0OR2.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0R2B.L.
0R2B.L vs 0IP1.L Comparison
0R2B.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0R2B.L stands at 134.91B. In comparison, 0IP1.L has a market cap of 206.08M. Regarding current trading prices, 0R2B.L is priced at $188.51, while 0IP1.L trades at $28.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0R2B.L currently has a P/E ratio of 21.82, whereas 0IP1.L's P/E ratio is 15.41. In terms of profitability, 0R2B.L's ROE is +0.07%, compared to 0IP1.L's ROE of +0.02%. Regarding short-term risk, 0R2B.L is more volatile compared to 0IP1.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0R2B.L.
0R2B.L vs 0NES.L Comparison
0R2B.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0R2B.L stands at 134.91B. In comparison, 0NES.L has a market cap of 202.66M. Regarding current trading prices, 0R2B.L is priced at $188.51, while 0NES.L trades at $1.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0R2B.L currently has a P/E ratio of 21.82, whereas 0NES.L's P/E ratio is 9.35. In terms of profitability, 0R2B.L's ROE is +0.07%, compared to 0NES.L's ROE of -0.16%. Regarding short-term risk, 0R2B.L is more volatile compared to 0NES.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0R2B.L.
0R2B.L vs 0DYQ.L Comparison
0R2B.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0R2B.L stands at 134.91B. In comparison, 0DYQ.L has a market cap of 160.46M. Regarding current trading prices, 0R2B.L is priced at $188.51, while 0DYQ.L trades at $11.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0R2B.L currently has a P/E ratio of 21.82, whereas 0DYQ.L's P/E ratio is 6.16. In terms of profitability, 0R2B.L's ROE is +0.07%, compared to 0DYQ.L's ROE of -0.05%. Regarding short-term risk, 0R2B.L is more volatile compared to 0DYQ.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0R2B.L.
0R2B.L vs 0H8I.L Comparison
0R2B.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0R2B.L stands at 134.91B. In comparison, 0H8I.L has a market cap of 153.72M. Regarding current trading prices, 0R2B.L is priced at $188.51, while 0H8I.L trades at $1.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0R2B.L currently has a P/E ratio of 21.82, whereas 0H8I.L's P/E ratio is -11.36. In terms of profitability, 0R2B.L's ROE is +0.07%, compared to 0H8I.L's ROE of -0.10%. Regarding short-term risk, 0R2B.L is less volatile compared to 0H8I.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0R2B.L.
0R2B.L vs 0QON.L Comparison
0R2B.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0R2B.L stands at 134.91B. In comparison, 0QON.L has a market cap of 121.41M. Regarding current trading prices, 0R2B.L is priced at $188.51, while 0QON.L trades at $3.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0R2B.L currently has a P/E ratio of 21.82, whereas 0QON.L's P/E ratio is 9.14. In terms of profitability, 0R2B.L's ROE is +0.07%, compared to 0QON.L's ROE of +0.05%. Regarding short-term risk, 0R2B.L is more volatile compared to 0QON.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0R2B.L.